These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 23758961)
1. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Sully BG; Julious SA; Nicholl J Trials; 2013 Jun; 14():166. PubMed ID: 23758961 [TBL] [Abstract][Full Text] [Related]
2. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. Walters SJ; Bonacho Dos Anjos Henriques-Cadby I; Bortolami O; Flight L; Hind D; Jacques RM; Knox C; Nadin B; Rothwell J; Surtees M; Julious SA BMJ Open; 2017 Mar; 7(3):e015276. PubMed ID: 28320800 [TBL] [Abstract][Full Text] [Related]
3. An investigation of the impact of futility analysis in publicly funded trials. Sully BG; Julious SA; Nicholl J Trials; 2014 Feb; 15():61. PubMed ID: 24533447 [TBL] [Abstract][Full Text] [Related]
4. Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme. Raftery J; Young A; Stanton L; Milne R; Cook A; Turner D; Davidson P Health Technol Assess; 2015 Feb; 19(11):1-138. PubMed ID: 25671821 [TBL] [Abstract][Full Text] [Related]
5. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA Cook JA; Julious SA; Sones W; Hampson LV; Hewitt C; Berlin JA; Ashby D; Emsley R; Fergusson DA; Walters SJ; Wilson EC; MacLennan G; Stallard N; Rothwell JC; Bland M; Brown L; Ramsay CR; Cook A; Armstrong D; Altman D; Vale LD Health Technol Assess; 2019 Oct; 23(60):1-88. PubMed ID: 31661431 [TBL] [Abstract][Full Text] [Related]
6. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. McDonald AM; Knight RC; Campbell MK; Entwistle VA; Grant AM; Cook JA; Elbourne DR; Francis D; Garcia J; Roberts I; Snowdon C Trials; 2006 Apr; 7():9. PubMed ID: 16603070 [TBL] [Abstract][Full Text] [Related]
7. Recruitment patterns in multicentre randomised trials fit more closely to Price's Law than the Pareto Principle: A review of trials funded and published by the United Kingdom Health Technology Assessment Programme. Knowlson C; Dean A; Doherty L; Fairhurst C; Brealey S; Torgerson DJ Contemp Clin Trials; 2022 Feb; 113():106665. PubMed ID: 34968767 [TBL] [Abstract][Full Text] [Related]
8. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. Billingham SA; Whitehead AL; Julious SA BMC Med Res Methodol; 2013 Aug; 13():104. PubMed ID: 23961782 [TBL] [Abstract][Full Text] [Related]
9. A study of target effect sizes in randomised controlled trials published in the Health Technology Assessment journal. Rothwell JC; Julious SA; Cooper CL Trials; 2018 Oct; 19(1):544. PubMed ID: 30305146 [TBL] [Abstract][Full Text] [Related]
10. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. Chalmers I; Rounding C; Lock K BMJ; 2003 Nov; 327(7422):1017. PubMed ID: 14593034 [TBL] [Abstract][Full Text] [Related]
11. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Campbell MK; Snowdon C; Francis D; Elbourne D; McDonald AM; Knight R; Entwistle V; Garcia J; Roberts I; Grant A; Grant A; Health Technol Assess; 2007 Nov; 11(48):iii, ix-105. PubMed ID: 17999843 [TBL] [Abstract][Full Text] [Related]
13. Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials. Herbert E; Julious SA; Goodacre S Trials; 2019 Aug; 20(1):493. PubMed ID: 31399148 [TBL] [Abstract][Full Text] [Related]
14. The reporting of coenrolment in protocols of publicly funded randomized controlled trials was infrequent and variable. Maslekar T; Peat S; Karim J; Moriarty C; Jayne DG; Chapman SJ J Clin Epidemiol; 2021 May; 133():94-100. PubMed ID: 33484839 [TBL] [Abstract][Full Text] [Related]
15. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA). Brettschneider C; Lühmann D; Raspe H GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289 [TBL] [Abstract][Full Text] [Related]
16. Using digital tools in the recruitment and retention in randomised controlled trials: survey of UK Clinical Trial Units and a qualitative study. Blatch-Jones A; Nuttall J; Bull A; Worswick L; Mullee M; Peveler R; Falk S; Tape N; Hinks J; Lane AJ; Wyatt JC; Griffiths G Trials; 2020 Apr; 21(1):304. PubMed ID: 32245506 [TBL] [Abstract][Full Text] [Related]
17. Budgeting of non-commercial clinical trials: development of a budget tool by a public funding agency. Nevens H; Harrison J; Vrijens F; Verleye L; Stocquart N; Marynen E; Hulstaert F Trials; 2019 Dec; 20(1):714. PubMed ID: 31829233 [TBL] [Abstract][Full Text] [Related]
18. The completeness of intervention descriptions in published National Institute of Health Research HTA-funded trials: a cross-sectional study. Douet L; Milne R; Anstee S; Habens F; Young A; Wright D BMJ Open; 2014 Jan; 4(1):e003713. PubMed ID: 24384896 [TBL] [Abstract][Full Text] [Related]
19. Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials. Raftery J; Fairbank E; Douet L; Dent L; Price A; Milne R; Walley T Trials; 2012 Aug; 13():140. PubMed ID: 22906196 [TBL] [Abstract][Full Text] [Related]
20. Role of feasibility and pilot studies in randomised controlled trials: a cross-sectional study. Blatch-Jones AJ; Pek W; Kirkpatrick E; Ashton-Key M BMJ Open; 2018 Sep; 8(9):e022233. PubMed ID: 30257847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]